Linlu Ma

4.7k total citations · 2 hit papers
26 papers, 1.6k citations indexed

About

Linlu Ma is a scholar working on Hematology, Molecular Biology and Epidemiology. According to data from OpenAlex, Linlu Ma has authored 26 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 5 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Linlu Ma's work include Acute Myeloid Leukemia Research (4 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers) and Multiple Myeloma Research and Treatments (2 papers). Linlu Ma is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers) and Multiple Myeloma Research and Treatments (2 papers). Linlu Ma collaborates with scholars based in China and United States. Linlu Ma's co-authors include Xinghuan Wang, Xian‐Tao Zeng, Hong Weng, Di Huang, Zhihua Yang, Fuling Zhou, Nan Zhang, Xiaoyan Liu, Yuxing Liang and Jinxian Wu and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Nutrients.

In The Last Decade

Linlu Ma

22 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better?

2020 1.2k citations Linlu Ma, Xinghuan Wang et al. Military Medical Research profile →
Global burden of hematologic malignancies and evolution patterns over the past 30 years

2023 168 citations Nan Zhang, Jinxian Wu et al. Blood Cancer Journal profile →

Peers

Countries citing papers authored by Linlu Ma

Since Specialization

Citations

This map shows the geographic impact of Linlu Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linlu Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linlu Ma more than expected).

Fields of papers citing papers by Linlu Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linlu Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linlu Ma. The network helps show where Linlu Ma may publish in the future.

Co-authorship network of co-authors of Linlu Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Linlu Ma. A scholar is included among the top collaborators of Linlu Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linlu Ma. Linlu Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Jab1 promotes immune evasion and progression in acute myeloid leukemia models under oxidative stress 2025 ·Journal of Clinical Investigation ·Nan Zhang, Qian Wang, Ping Chen, Liu L, Zhiying Wang, Linlu Ma, Yuxing Liang, Jinxian Wu, Xinqi Li, Xiaoyan Liu, Fuling Zhou	0
2	Critical role of niche S100A8 for acute myeloid leukemia progression and hematopoiesis regeneration 2025 ·Blood Advances ·Xiaoyan Liu, (unknown), Xinqi Li, (unknown), (unknown), Tingting Huang, Linlu Ma, Ping Chen, Qian Wang, Nan Zhang, (unknown), Yuxin Tan, Hongqiang Jiang, Yuxing Liang, (unknown), (unknown), (unknown), Xian Zhang, Fuling Zhou	1
3	Azelaic acid attenuates CCL2/CCR2 axis-mediated skin trafficking of acute myeloid leukemia cells through NF-κB/MAPK signaling modulation in keratinocytes 2025 ·BMC Cancer ·(unknown), Linlu Ma, Tingting Huang, (unknown), Fuling Zhou, Xiaoyan Liu	0
4	FLT3-selective PROTAC: Enhanced safety and increased synergy with Venetoclax in FLT3-ITD mutated acute myeloid leukemia 2024 ·Cancer Letters ·Yuxin Tan, (unknown), Qian Wang, Rong Xu, (unknown), Ping Chen, Linlu Ma, (unknown), Hongqiang Jiang, Nan Zhang, Jinxian Wu, Xinqi Li, Xinyi Guo, Chao Wang, Hai‐Bing Zhou, Fuling Zhou	12
5	Development of a risk assessment model for cardiac injury in patients newly diagnosed with acute myeloid leukemia based on a multicenter, real-world analysis in China 2024 ·BMC Cancer ·Linlu Ma, Qian Wang, Xinqi Li, Yufeng Shang, Nan Zhang, Jinxian Wu, Yuxing Liang, Guopeng Chen, Yuxin Tan, Xiaoyan Liu, Guolin Yuan, Fuling Zhou	6
6	Clinical and immunological characteristics of high-risk double-hit multiple myeloma 2024 ·BMC Cancer ·Yufeng Shang, Guopeng Chen, Li Liu, (unknown), Xinqi Li, Hui Shen, Yuxin Tan, Linlu Ma, (unknown), Weida Wang, Xiaoqin Chen, Zhongjun Xia, Xiaoyan Liu, Fuling Zhou	0
7	Prevalence trends of anemia impairment in adolescents and young adults with HIV/AIDS 2024 ·BMC Public Health ·Xinqi Li, Nan Zhang, Linlu Ma, Qian Wang, Yuxing Liang, Xiaoyan Liu, Fuling Zhou	2
8	Global burden of hematologic malignancies and evolution patterns over the past 30 years breakdown → 2023 ·Blood Cancer Journal ·Nan Zhang, Jinxian Wu, (unknown), Yuxing Liang, Xinqi Li, Ping Chen, Linlu Ma, Xiaoyan Liu, Fuling Zhou	168
9	Prevalence Trends of Anemia Impairment in Adolescents and Young Adults with HIV/AIDS 2023 ·Blood ·Nan Zhang, Xinqi Li, Linlu Ma, Yuxing Liang, Xiaoyan Liu, Fuling Zhou	1
10	Comprehensive analysis of clinical prognostic features and tumor microenvironment landscape of CD11b+CD64+ patients with acute myeloid leukemia 2023 ·Cellular Oncology ·Qian Wang, Nan Zhang, (unknown), Linlu Ma, Yuxin Tan, Xiaoyan Liu, Jinxian Wu, Ping Chen, Xinqi Li, Yuxing Liang, Fuling Zhou	0
11	Distributions and Trends of the Global Burden of Colorectal Cancer Attributable to Dietary Risk Factors over the Past 30 Years 2023 ·Nutrients ·Yuxing Liang, Nan Zhang, Miao Wang, Yixin Liu, Linlu Ma, Qian Wang, Qian Yang, Xiaoyan Liu, Fuling Zhou, Yongchang Wei	32
12	Magnetically Actuated Hydrogel Stamping-Assisted Cellular Mechanical Analyzer for Stored Blood Quality Detection 2023 ·ACS Sensors ·Le Yu, Longfei Chen, Yantong Liu, Jiaomeng Zhu, Fang Wang, Linlu Ma, Kezhen Yi, (unknown), Fuling Zhou, Fubing Wang, Long Bai, Yimin Zhu, Xuan Xiao, Yi Yang	10
13	A novel organic arsenic derivative MZ2 remodels metabolism and triggers mtROS-mediated apoptosis in acute myeloid leukemia 2022 ·Journal of Cancer Research and Clinical Oncology ·Ping Chen, Wenyan She, Chao-Chao Yu, (unknown), Xinqi Li, Linlu Ma, Nan Zhang, Hongqiang Jiang, Xiaoyan Liu, Jinxian Wu, Qian Wang, Hui Shen, Fuling Zhou	2
14	Space-time-regulated imaging analyzer for smart coagulation diagnosis 2022 ·Cell Reports Medicine ·Longfei Chen, Le Yu, Yantong Liu, (unknown), Linlu Ma, Pengfu Tian, Jiaomeng Zhu, Fang Wang, Kezhen Yi, (unknown), Fuling Zhou, Yi Yang, Yanxiang Cheng, Long Bai, Fubing Wang, Yimin Zhu	18
15	Touchable cell biophysics property recognition platforms enable multifunctional blood smart health care 2021 ·Microsystems & Nanoengineering ·Longfei Chen, Yantong Liu, (unknown), Linlu Ma, (unknown), Le Yu, Fang Wang, Jiaomeng Zhu, Xuejia Hu, Kezhen Yi, Yi Yang, Hui Shen, Fuling Zhou, Xiaoqi Gao, Yanxiang Cheng, Long Bai, (unknown), Fubing Wang, Yimin Zhu	21
16	Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better? breakdown → 2020 ·Military Medical Research ·Linlu Ma, Xinghuan Wang, Zhihua Yang, Di Huang, Hong Weng, Xian‐Tao Zeng	1205
17	Tracing asymptomatic SARS-CoV-2 carriers among 3674 hospital staff:a cross-sectional survey 2020 ·EClinicalMedicine ·Fuling Zhou, Jingfeng Li, Mengxin Lü, Linlu Ma, Yunbao Pan, Xiaoyan Liu, Xiaobin Zhu, Chao Hu, Sanyun Wu, Liangjun Chen, Yi Wang, Yongchang Wei, Yirong Li, Haibo Xu, Xinghuan Wang, Lin Cai	14
18	Comprehensive Survey of Clinical Trials Registration for Melanoma Immunotherapy in the ClinicalTrials.gov 2020 ·Frontiers in Pharmacology ·Yan‐Bo Wang, Gang Lv, Fenghua Xu, Linlu Ma, Yong-ming Yao	5
19	Clinical Trial Registration and Reporting: Drug Therapy and Prevention of Cardiac-Related Infections 2019 ·Frontiers in Pharmacology ·Linlu Ma, Yang Qiu, (unknown), Yun Chen, (unknown), Binghui Li, Ming-Juan Zhao, Xincan Liu	5
20	The Top-100 Highly Cited Original Articles on Drug Therapy for Ventilator-Associated Pneumonia 2019 ·Frontiers in Pharmacology ·Chaoyang Wang, Binghui Li, Linlu Ma, Ming-Juan Zhao, Tong Deng, Yinghui Jin, Xuequn Ren	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact